investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Clinical validation of the CD32b biomarker on the European market

Investigator from BioInvent (Sweden)

0 Collaborator(s)

Funding source

European Commission (Belgium)

No posts

Related projects

Bruno Calabretta

Targeting the C/EBPalpha-Gfi-pathway in CML stem cells

Leukaemia

Hematology and hematologic malignancies Pathology

Derek L Stirewalt

Discovery and Optimization of AML Prognostic Biomarkers

Leukaemia

Pediatric oncology or childhood cancer

Nya D Nelson

Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita

Lip, oral cavity Leukaemia

Pathology

Timothy Jensen Henrich

Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics

Leukaemia

Hematology and hematologic malignancies

Karin L Gaensler

Efficacy and Safety of Novel CD80 IL15 IL15Ra Expressing Autologous AML Vaccines

Leukaemia

Hematology and hematologic malignancies

Catherine Ju-Ying Wu

Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Catherine Ju-Ying Wu

(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL

Leukaemia

Hematology and hematologic malignancies Pathology

Peter Inskip

Cancer Risk in Chernobyl Clean-up Workers from Baltic Countries

Thyroid Leukaemia Brain, nervous system

Radiation Oncology

Wing Leung

KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN

Leukaemia

Pediatric oncology or childhood cancer